Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRI
| Status: | Archived |
|---|---|
| Conditions: | Chronic Obstructive Pulmonary Disease, Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | November 2008 |
| End Date: | April 2013 |
Assessment of Arformoterol for COPD Using Hyperpolarized 3He MRI
The purpose of this study is to determine efficacy of MR imaging with hyperpolarized
helium-3 gas in COPD patients both before and after treatment.
Hyperpolarized Helium Lung imaging has already been tested and proven to be scientifically
possible in patients with a number of pulmonary disorders. However there is limited data on
the sensitivity of this imaging technique, which would be essential for clinical use. This
study is a double blinded study with two cohorts, each cohort being made up of patients with
confirmed diagnosis of COPD. One group will receive a placebo while the other will receive
treatment. A comparison of the data will resume once twenty patients have been consented and
completed the study procedures.
We found this trial at
1
site
Umass Memorial Medical Center UMass Memorial Medical Center is the region's trusted academic medical center,...
Click here to add this to my saved trials
